CAPR

13.07

1.32% 0.17

Dopo l'orario di chiusura: 13.10 0.03 +0.23%

Capricor Therapeutics Inc (CAPR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché CAPR Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$12.90

Aprire:

$12.64

Volume 24 ore:

5.46M

Relative Volume:

1.56

Capitalizzazione di mercato:

$594.29M

Reddito:

$27.10M

Utile/perdita netta:

$-24.31M

Rapporto P/E:

-11.17

EPS:

-1.17

Flusso di cassa netto:

$-33.33M

1 W Prestazione:

-1.43%

1M Prestazione:

-30.92%

6M Prestazione:

+174.58%

1 anno Prestazione:

+199.77%

Intervallo 1D:

$12.57

$13.53

Intervallo di 1 settimana:

$12.25

$14.50

Portata 52W:

$3.52

$23.40

Capricor Therapeutics Inc Stock (CAPR) Company Profile

Nome

Capricor Therapeutics Inc

Settore

Healthcare (1176)

Industria

Biotechnology (673)

Telefono

(310) 358-3200

Indirizzo

8840 WILSHIRE BLVD, BEVERLY HILLS, CA

Dipendente

102

Cinguettio

@Capricor

Prossima data di guadagno

2024-11-12

Ultimi documenti SEC

CAPR's Discussions on Twitter

Confronta CAPR con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CAPR Capricor Therapeutics Inc	13.07	594.29M	27.10M	-24.31M	-33.33M	-0.83
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Capricor Therapeutics Inc Stock (CAPR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-10-21	Iniziato	Piper Sandler	Overweight
2024-05-17	Iniziato	Oppenheimer	Outperform
2024-01-05	Iniziato	Cantor Fitzgerald	Overweight
2022-10-26	Iniziato	Ladenburg Thalmann	Buy
2018-12-26	Downgrade	Maxim Group	Buy → Hold
2018-01-26	Reiterato	H.C. Wainwright	Buy
2017-09-15	Reiterato	H.C. Wainwright	Buy
2017-02-13	Ripresa	Rodman & Renshaw	Buy
2016-07-06	Ripresa	H.C. Wainwright	Buy
2016-06-15	Iniziato	ROTH Capital	Buy

Mostra tutto

Capricor Therapeutics Inc Borsa (CAPR) Ultime notizie

Dec 20, 2024

(CAPR) Trading Advice - Stock Traders Daily

Dec 20, 2024

Dec 18, 2024

Capricor Therapeutics (CAPR) Stock Dips Amid Biotech Sector Decl - GuruFocus.com

Dec 18, 2024

Dec 16, 2024

Capricor Therapeutics Inc (NASDAQ:CAPR) Short Interest Update - MarketBeat

Dec 16, 2024

Dec 14, 2024

Capricor Therapeutics (NASDAQ:CAPR) Trading Down 5.3%Here's Why - MarketBeat

Dec 14, 2024

Dec 13, 2024

Capricor Therapeutics (CAPR) Stock Drops Amid Volatile Biotech Sector - GuruFocus.com

Dec 13, 2024

Dec 12, 2024

High Growth Tech Stocks To Watch In December 2024 - Simply Wall St

Dec 12, 2024

RFK Jr. could prove a surprise boon for stem-cell stocks with pivotal year ahead - MarketWatch

Dec 12, 2024

Some Capricor Therapeutics, Inc. (NASDAQ:CAPR) Shareholders Look For Exit As Shares Take 27% Pounding - Simply Wall St

Dec 12, 2024

Dec 10, 2024

(CAPR) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Dec 10, 2024

Dec 09, 2024

250,204 Shares in Capricor Therapeutics Inc (NASDAQ:CAPR) Purchased by Point72 Asset Management L.P. - MarketBeat

Dec 09, 2024

Dec 07, 2024

Deramiocel's Promise Brightens Capricor's Outlook, With Strings Attached (NASDAQ:CAPR) - Seeking Alpha

Dec 07, 2024

Dec 06, 2024

Capricor: Additional Deramiocel Data Bodes Well For Initiated Rolling BLA Submission - Seeking Alpha

Dec 06, 2024

Dec 05, 2024

Jones Trading keeps $40 target on Capricor Therapeutics By Investing.com - Investing.com UK

Dec 05, 2024

Dec 03, 2024

Piper Sandler maintains $35 target on Capricor shares By Investing.com - Investing.com Canada

Dec 03, 2024

Dec 02, 2024

Capricor Therapeutics (CAPR) Stock Surges Amid Positive Analyst Ratings - GuruFocus.com

Dec 02, 2024

TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail

Dec 02, 2024

Capricor Therapeutics to Present at Upcoming Investor Conferences - The Manila Times

Dec 02, 2024

Capricor Therapeutics to Present at Major Healthcare Conferences in December | CAPR Stock News - StockTitan

Dec 02, 2024

Walmart Inc (WMT-N) QuotePress Release - The Globe and Mail

Dec 02, 2024

Dec 01, 2024

Capricor Therapeutics Inc (NASDAQ:CAPR) Receives $34.50 Average Price Target from Analysts - MarketBeat

Dec 01, 2024

Nov 27, 2024

Capricor Therapeutics (CAPR) Sees Stock Surge Amid Positive Anal - GuruFocus.com

Nov 27, 2024

Nov 26, 2024

Pork Cutout (KMG25) Quote - The Globe and Mail

Nov 26, 2024

Nov 24, 2024

Capricor Therapeutics Executes Collaboration Agreement and Exclusive License Option with Janssen Biotech - Marketscreener.com

Nov 24, 2024

Nov 21, 2024

Capricor wins key EU designations for the lead asset - MSN

Nov 21, 2024

Nov 20, 2024

Capricor stock on watch after key EU designations (CAPR:NASDAQ) - Seeking Alpha

Nov 20, 2024

Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency - The Manila Times

Nov 20, 2024

Nov 18, 2024

(CAPR) Proactive Strategies - Stock Traders Daily

Nov 18, 2024

Capricor Therapeutics shares rated Buy by Jones Trading, boosted by DMD-CM therapy - Investing.com Canada

Nov 18, 2024

What is HC Wainwright's Estimate for CAPR FY2024 Earnings? - MarketBeat

Nov 18, 2024

Nov 17, 2024

KBW Bank Index (BKX) QuotePress Release - The Globe and Mail

Nov 17, 2024

Nov 16, 2024

Capricor Therapeutics Inc (NASDAQ:CAPR) Short Interest Down 14.6% in October - MarketBeat

Nov 16, 2024

Is Capricor Therapeutics (CAPR) the Best Multibagger Stock to Buy Heading into 2025? - Yahoo Finance

Nov 16, 2024

Nov 15, 2024

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024

Capricor Therapeutics Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 15, 2024